
Number of publications published per year by Wright, Matthew C.. (Source : PubMed)

Distribution of publications types for Wright, Matthew C.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Anti-tumor effect of CT-322 as an adnectin inhibitor of vascular endothelial growth factor receptor-2.
MAbs
2010;2;2
The c-Rel subunit of nuclear factor-kappaB regulates murine liver inflammation, wound-healing, and hepatocyte proliferation.
Hepatology
2010;51;3
A role for the pregnane X receptor in flucloxacillin-induced liver injury.
Hepatology
2010
Low affinity glucocorticoid binding site ligands as potential anti-fibrogenics.
Comp Hepatol
2009;8
Targeting liver myofibroblasts: a novel approach in anti-fibrogenic therapy.
Hepatology international
2008;2;4
Antibody-targeted myofibroblast apoptosis reduces fibrosis during sustained liver injury.
J. Hepatol.
2008;49;1

A mechanism for the anti-fibrogenic effects of the pregnane X receptor (PXR) in the liver: inhibition of NF-kappaB?
Toxicology
2008;246;1
Expression of CYP2S1 in human hepatic stellate cells.
FEBS Lett.
2007;581;4
Intraoperative apnea: medication error with disclosure (simulation case scenario).
Simulation in healthcare : journal of the Society for Simulation in Healthcare
2007;2;1


Pregnane X receptor activators inhibit human hepatic stellate cell transdifferentiation in vitro.
Gastroenterology
2006;131;1
[ See timeline ] [ See all publications ]
means that Wright, Matthew C. has 14 papers cited a least 14 times - methodology
Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, UK.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.